simultaneous sirna targeting of src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line同时可以阻止针对src和下游信号分子抑制肿瘤的形成和转移人类乳腺癌细胞系模型.pdfVIP

下载本文档

9
0
约 11页
2017-09-12 发布于上海
举报
版权申诉

simultaneous sirna targeting of src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line同时可以阻止针对src和下游信号分子抑制肿瘤的形成和转移人类乳腺癌细胞系模型.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

simultaneous sirna targeting of src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line同时可以阻止针对src和下游信号分子抑制肿瘤的形成和转移人类乳腺癌细胞系模型

Simultaneous siRNA Targeting of Src and Downstream Signaling Molecules Inhibit Tumor Formation and Metastasis of a Human Model Breast Cancer Cell Line Jeffrey D. Bjorge1,2, Andy S. Pang1,2, Melanie Funnell1,2, Ke Yun Chen1,2, Roman Diaz3,4, Anthony M. Magliocco3,4, Donald J. Fujita1,2* 1 Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada, 2 Southern Alberta Cancer Research Institute, University of Calgary, Calgary, Alberta, Canada, 3 Department of Oncology, University of Calgary, Calgary, Alberta, Canada, 4 Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada Abstract Background: Src and signaling molecules downstream of Src, including signal transducer and activator of transcription 3 (Stat3) and cMyc, have been implicated in the development, maintenance and/or progression of several types of human cancers, including breast cancer. Here we report the ability of siRNA-mediated Src knock-down alone, and simultaneous knock-down of Src and Stat3 and/or cMyc to inhibit the neoplastic phenotype of a highly metastatic human model breast cancer cell line, MDA-MB-435S, a widely used model for breast cancer research. Methodology/Results: Src and its downstream signaling partners were specifically targeted and knocked-down using siRNA. Changes in the growth properties of the cultured cancer cells/tumors were documented using assays that included anchorage-dependent and -independent (in soft agar) cell growth, apoptosis, and both primary and metastatic tumor growth in the mouse tumor model. siRNA-mediated Src knock-down alone, and simultaneous knock-down of Src and Stat3 and/or cMyc inhibited the neoplastic phenotype of a highly metastatic human model breast cancer cell line, MDA-MB-435S. This knock-down resulted in reduced growth in monolayer and soft agar cultures, and a re